The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study
Nicholas A. Livingston, Michael Davenport, Michael Head, Rachel Mosher Henke, Lavonia Smith LeBeau, Teresa B. Gibson, Anne N. Banducci, Alexis Sarpong, Saketh Jayanthi, Clara E Roth, Jessica Camacho-Cook, Frank Meng, Justeen Hyde, Norah Mulvaney‐Day, Mackenzie White, Daniel Chen, Michael D. Stein, Risa B. Weisberg
Topics & Concepts
BuprenorphineMedicineOpioid use disorderMethadoneReceiptCohortPandemicVeterans AffairsOpiate Substitution TreatmentFamily medicineEmergency medicinePsychiatryOpioidCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseReceptorComputer scienceWorld Wide WebInfectious disease (medical specialty)Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes